HMGA2 nuclear immunoreactivity, even if not specific, is present in most cases of DAM and could be useful in distinguishing it from other mesenchymal tumors [37]; however, as mentioned above, this was not tested in any of the cases occurring in pregnancy. Here, HMGA2 is linked to mesenchymal cell neoplasm.